Saturday, September 13, 2008 7:43:41 PM
All of the above. And I have no desire to see the price dip so I can buy more, because I already have a ton of shares, way too many to easily flip in anticipation of a dip with the hope of buying back later at a lower price, assuming the typical daily share volume for OXBO. So essentially I will sit with what I have, and as far as I'm concerned, the best thing will be for the pps to go up, not down, lol.
All that said, I learned a long time ago that there's no point in making specific pps projections, because I'm invariably wrong. I don't think, however, that it will get as low as you hope, barring major problems with the FDA, and I think the pps has the potential to go a lot higher, sooner, than you do. jmho.
All that said, I learned a long time ago that there's no point in making specific pps projections, because I'm invariably wrong. I don't think, however, that it will get as low as you hope, barring major problems with the FDA, and I think the pps has the potential to go a lot higher, sooner, than you do. jmho.
Recent TENX News
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/20/2026 09:05:19 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 10:55:54 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 09:26:02 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 08:31:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 09:08:07 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:56:40 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/12/2026 09:01:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2026 08:06:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 12:00:07 PM
- Tenax Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/12/2026 11:00:00 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/08/2026 10:19:02 PM
- Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/08/2026 08:05:00 PM
- Tenax Therapeutics Appoints Timothy Healey, MBA as Chief Commercial Officer • GlobeNewswire Inc. • 05/04/2026 11:00:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/22/2026 12:19:57 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/22/2026 12:17:37 PM
